
EXCLUSIVE Do aliens exist? British astronaut Tim Peake thinks there IS 'complex, intelligent life' beyond Earth - and says we're 'close' to finding it
If aliens exist, surely Tim Peake is one of a select group of humans who have been the closest to them.
The British astronaut spent six months in space between 2015 and 2016, living and working on the International Space Station (ISS), 250 miles above Earth.
Although he didn't have any extraterrestrial encounters while up there, Major Peake said he thinks aliens most likely do exist.
Speaking exclusively to MailOnline, the 53-year-old, from Chichester in Sussex, said Earth is 'actually a pretty small place', relatively speaking.
'When you look at just our own Milky Way galaxy with 200 billion stars, that's one of a number of hundreds of billions of galaxies that we can see,' he told MailOnline.
'So the chances are that there is complex, intelligent life elsewhere in the universe.'
In April, scientists revealed that a faraway planet called K2-18b has large quantities of chemicals in its atmosphere that are suggestive of living organisms.
Although the findings are to be confirmed, Major Peake said we are likely close to finding the definitive proof that aliens do exist.
'We know that the universe is abundant with water, it's abundant with the seeds of life,' the British spaceman told MailOnline.
'We've discovered so many thousands of exoplanets in our neighbourhood which are orbiting stars, many of which have very good signs of potential habitability with liquid oceans for example.
'Within the next five to 10 years, using the James Webb Space Telescope for example, we could even get to the situation where scientists feel confident enough to be able to say that they found signs of biological life on another planet.'
'It might be small bacteria, it might be algae, giving off some signs of biological processes.
'But that's the kind of thing that we're getting close to be able to say for sure.'
During his time on the ISS between December 2015 and June 2016, Major Peake completed the first British spacewalk, took part in 250 research experiments, and even managed to remotely run the London Marathon.
On January 15, 2016, he participated in the first spacewalk outside the ISS by a British astronaut with the dazzling blue of the Earth beneath him.
The historic event lasted nearly five hours, although it was cut short when American colleague Tim Kopra had water building up in his helmet.
During his time on the ISS, he became the first person to complete a spacewalk while sporting a Union flag on his shoulder. Pictured, prior to his spacewalk, January 14, 2016
Nearly a decade later, Major Peake reflects on the experience as 'very surreal' and difficult to put into words'.
'The feeling is a mixture of appreciating how remote and isolated our planet is,' he told MailOnline.
'I hesitate to use the word fragile because actually the planet's pretty robust – it's survived 4 billion years; it's got another 4 billion to go before the sun will cause its demise.
'But what you appreciate from space is not necessarily its fragility but its remoteness and the level of isolation against this vast black backdrop of the universe.
'And it strikes you that that is home – that's the only planet we've got to live on.
'On the one hand it makes you feel fairly small and insignificant but on the other hand it does make you appreciate that we are incredibly special.'
Major Peake spoke to MailOnline ahead of this summer's Goodwood Festival of Speed near his native Chichester where he's ambassador of the Future Lab exhibition showcasing the technologies of tomorrow.
He's already given the biggest indication yet that he's about to make a spectacular return into orbit after nearly a decade back on Earth.
Last year, he was confirmed as 'strategic advisor' for a mission led by US firm Axiom Space to send an all-UK team into space for the first time.
The trip will certainly require a seasoned astronaut to act as 'commander' akin to the captain on a ship – with Major Peake the most obvious contender.
Although he couldn't confirm whether he would indeed be commander of the mission, he said going to space is still 'always of interest'.
'I'm an astronaut who's fit and able to fly to space and command a mission,' he told MailOnline. 'So absolutely I'm willing and ready to command the mission and fly to space.'
Meet the astronauts tipped to fly into space as part of the all-UK mission with Tim Peake
Three Britons – including the world's first ever 'parastronaut' – are among the European Space Agency's first new cohort of astronauts in almost 15 years.
In November 2022, John McFall, Rosemary Coogan and Meganne Christian were named in a class of 17 men and women chosen from a whopping 22,523 applicants.
They will be hoping to follow in the footsteps of current British astronaut Tim Peake, who spent six months on the International Space Station (ISS) almost a decade ago.
Here's a closer look at the three adventurers, who may be joined by Major Peake himself on a trip to the ISS.
John McFall
Britain's John McFall was named as the world's first 'parastronaut' in November 2022
John McFall, 44, is a British father-of-three, surgical trainee and Paralympic medallist.
Originally from Frimley in Surrey, Mr McFall had his right leg amputated following a motorcycle accident in Thailand in 2000.
He was fitted with a prosthesis and is now working with the European Space Agency (ESA) to investigate how such a disability could affect a stint in space.
He won a bronze medal at the 2008 Paralympic Games in Beijing among other honours, before retiring to take up his medical studies at Cardiff University.
He has put his medical career on hold to work with ESA and follow his 'passion for science and life'.
Rosemary Coogan
Rosemary Coogan, 33, is an astrophysicist originally from Belfast in Northern Ireland.
She attended school in Brighton and gained two master's degrees from the University of Durham.
One of these focused on physics, mathematics, computer programming and astronomy, and the other on gamma-ray emission from black holes.
Coogan moved to the University of Sussex as a doctoral researcher, studying galaxy evolution and the activity of active galactic nuclei.
From a young age, she spent several weeks a year away from home onboard military training vessels and land bases as a Cadet Petty Officer with the Sea Cadets from 2002 to 2009.
Meganne Christian
Meganne Christian, 37, is a materials scientist graduate from the University of New South Wales in Sydney.
She was born in Pembury in Kent but moved to Australia at a young age and attended Illawarra Grammar School in Wollongong.
She said she was inspired to become an astronaut when one visited her school.
The materials scientist has worked at the National Research Council of Italy in Bologna and as a researcher at Concordia Station in Antarctica, one of the most remote places on Earth.
According to ESA, Meganne received several national awards for outstanding research in the field of engineering and industrial chemistry.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
3 hours ago
- The Guardian
Is it true that … taking collagen supplements slows signs of ageing?
Collagen is one of the body's building blocks. Made up of amino acids absorbed from the protein we eat, there are more than 20 subtypes found everywhere – from our bones and muscles to organs. Types I, II, and III are the most common in skin, cartilage and connective tissue, helping with strength and elasticity. In recent years collagen has become known as the protein that keeps the skin on our face young-looking, with collagen powders and pills promising to slow signs of ageing – but is there any truth in those claims? Dr Afshin Mosahebi, a professor in plastic surgery at University College London, says the science is 'dubious', with a lack of large-scale, peer-reviewed studies. 'There's no direct evidence that collagen, taken on its own, can do anything more than eating enough protein,' says Mosahebi. He says it's true that, as we age, changes in collagen level makes the skin on our face start to look 'crinkly' and less firm, but that it's wrong to assume that simply supplementing collagen is the solution. 'When you eat something it doesn't go directly to your skin. Of course, parts of it are eventually absorbed and used in skin repair, but it's not going to go straight from your mouth to your face and wrinkles.' He adds that using skincare containing collagen won't make a long-term difference to ageing either, as 'it doesn't penetrate the skin itself'. Instead, he says that the way we age is down to genetics (like having fair skin that's sensitive to the sun) and our lifestyles. His tips for slowing that process down include making sure to eat a balanced diet that includes proteins, keeping away from the sun, avoiding smoking, staying hydrated and keeping your skin moisturised with products like hyaluronic acid.


The Independent
3 hours ago
- The Independent
University unveils plans for £35m brewing and distilling ‘centre for excellence'
A Scottish university is aiming to raise £35 million for a 'world-renowned' Centre for Sustainable Brewing and Distilling to help the alcohol industry deal with the climate crisis. Heriot-Watt University, based in Edinburgh, already has an International Centre for Brewing and Distilling (ICBD), which since 1989 has been considered the world's leading educational establishment for courses in brewing and distilling. However its history of teaching brewing dates back more than a century, to 1903. Many of the best-known Scotch whisky master distillers and brewers – including BrewDog co-founder Martin Dickie, master distiller at Arbikie Highland Estate Kirsty Black, and David Wilkinson, head distiller at Edinburgh Gin – studied at the ICBD. The new centre is intended to function as a living laboratory, constructed with low-carbon materials with the aim to access all of its power through clean energy. The Centre for Sustainable Brewing and Distilling (CSBD) will embrace the latest green technologies and sustainable practices so Heriot-Watt can evolve its teaching and research to meet the challenges of the future. It is hoped to include plug-and-play brewing and distilling testbeds, enabling companies to trial production methods before full-scale adoption, as well as advanced sustainability research labs to develop low-carbon distillation techniques. The CSBD will offer specialist training programmes, including graduate apprenticeships, executive education, and research-led industry collaborations. Professor Gillian Murray, Heriot-Watt's deputy principal for business and enterprise, said: 'Heriot-Watt's association with teaching brewing and distilling dates back to 1903. 'However, it was over 35 years ago that our unique brewing and distilling teaching and research facility – recognised by the Institute of Brewing and Distilling – was established. 'Ever since it has been home to vibrant research and unique innovation that has revolutionised both industries. Our teaching provides the perfect breeding ground for ground-breaking new ideas from the brightest and best students – from use of raw materials and fermentation to chemical engineering, bottling, packaging and marketing. 'But we have big aspirations for the future. That is why we are unveiling a revamped and revitalised approach to academic research into brewing and distilling through a new world-renowned centre for excellence, the Centre for Sustainable Brewing and Distilling. 'We want to encourage people from around the world to help us fund this multimillion-pound vision that sets the next generation of brilliant minds the challenge of finding ever more economically-viable and environmentally-sustainable ways of driving both industries forward into the 22nd century.' Ewan Andrew, president of global supply chain at drinks company Diageo, said: 'We back Heriot-Watt's plans for a Centre for Sustainable Brewing and Distilling. The CSBD will provide a new, modern environment for innovation, support the development of groundbreaking sustainable processes, and develop a new highly-skilled workforce that helps future-proof this vitally important economic contributor for decades to come.' Jo Marshall, brand director at Carlsberg Britvic, which owns McEwan's Export, said: 'Over a century ago, McEwan's founder William McEwan collaborated with the university's very first professor of brewing, Emil Westergaard, to drive forward brewing innovation. 'It's inspiring to see that same pioneering spirit lives on today in plans for a new centre dedicated to sustainable talent development and innovation.'


BBC News
13 hours ago
- BBC News
Capivasertib given to breast cancer patients in Wales for first time
A drug which has been proven to extend the life of some people with incurable breast cancer has been given to patients on the NHS in Wales for the first Buchan, 62, who has terminal breast cancer, said capivasertib would allow her to see her son's wedding and gave her "hope".Half of women with breast cancer fuelled by the hormone oestrogen are likely to see their life expectancy double when capivasertib is combined with hormone therapy, research has Rob Jones, who co-led a study looking at capivasertib's effectiveness, said the drug offered "a real life impact for people to spend extra time with their relatives, with their friends". Breast cancer is the most common cancer in the UK, with one in seven women affected in their lifetimes and 75% surviving for 10 years or more after Wales, more than 2,000 people are diagnosed with breast cancer every which was developed by experts at Velindre Cancer Centre and Cardiff University, became available to breast cancer patients on the NHS in April. When Ms Buchan's first line of treatment for her terminal breast cancer stopped working, it was a the recent approval of capivasertib for use on the NHS alongside hormone therapy will allow her to enjoy more time with family and has a common genetic abnormality in her cancer which tests have shown responds well to the drug."To be told I had secondary breast cancer but my life can be extended, I think it's that hope you have to keep in your mind," said Ms Buchan from Barry, Vale of Glamorgan."I know that prior to the first line of treatment going down it was expected I'd live five or six years, maybe more. "The way I cope with this is by thinking about today and today is a good day."Ms Buchan is among thousands in the UK and millions worldwide who could benefit from the drug."I think I'm really lucky because I've got the most supportive husband, children and their partners and extended family and wonderful friends. "What this drug can do for me is allow me to see my son's wedding next year and to look into the future." Despite its approval for use globally by the US Food and Drug Administration (FDA) in 2023, capivasertib only became available to patients via the NHS in England and Wales this Simon Waters, consultant medical oncologist at Velindre Cancer Centre, said it was a "great opportunity now we've got to this point". "People have been working on it for a long time. It's great we can now put it in to practice as a standard treatment," he said. "We've been using a similar treatment for a smaller group of patients for a few years and that's had quite a lot of issues with side effects and we think this treatment will not only be more effective but also will have fewer issues with side effects. "It's also applicable to a larger group of patients with this common type of breast cancer." How does capivasertib work? The drug is suitable for those with certain gene mutations that affect up to half of people with hormone receptor positive secondary breast cancer - the most common type, which grows in the presence of hormone therapy usually works, eventually the cancer can become resistant to it.A clinical trial found a particular protein which drives the resistance can be neutralised when hormone therapy is combined with capivasertib. 'Doubling of survival time' Prof Rob Jones said: "Patients who received the hormone therapy with a placebo had an overall survival of around 20 months and those who received the capivasertib with the hormone therapy had an extra 39 months."It really is a doubling of survival time so that really is significant. It's not just a statistic - it's a real life impact for people to spend extra time with their relatives, with their friends."Dr Nicola Williams, national director of support and delivery at Health and Care Research Wales, said: "A breast cancer diagnosis can be devastating and one in seven women will be diagnosed with the disease in their lifetime. "This diagnosis is even more painful if you're told your cancer is incurable. "Thanks to the trial and the licensing of capivasertib, when used alongside a standard hormonal therapy, patients like Gwen now have the potential to receive a very significant extension in their lifespan and improved quality of life."